Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Dydrogesterone Alone With Dydrogesterone Plus Human Chorionic Gonadotrophin (HCG) in the Treatment of Threatened Miscarriage

NCT07608133 is registered in ClinicalTrials.gov with Pakistan Air Force (PAF) Hospital Islamabad as lead sponsor.

NCT NCT07608133
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07608133 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Dydrogesterone Alone With Dydrogesterone Plus Human Chorionic Gonadotrophin (HCG) in the Treatment of Threatened Miscarriage
Lead sponsor
Pakistan Air Force (PAF) Hospital Islamabad
Phase
Not applicable
Overall status
Completed
Start date
December 9, 2025
Completion date
May 15, 2026
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

early pregnancy bleeding, threatened miscarriage